Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Interleukin-10 as a novel biomarker of metabolic risk factors
Himani Kulshrestha1, Vani Gupta1, Sameeksha Mishra1
1Department of Physiology, King George's Medical University, Lucknow, India.
Insights
Lower levels of Interleukin-10 (IL-10), an adipocytokine from visceral fat, correlate with more metabolic risk factors in children. This suggests IL-10 may indicate metabolic health status.
Area of Science:
- Endocrinology
- Metabolic Syndrome Research
- Adipocytokine Signaling
Background:
- Interleukin-10 (IL-10) is an adipocytokine predominantly found in visceral fat.
- Its role in metabolic health requires further investigation.
Purpose of the Study:
- To examine the association between circulating Interleukin-10 levels and the number of metabolic risk factors in children.
- To determine if IL-10 can serve as a biomarker for metabolic disorders.
Main Methods:
- Plasma IL-10 levels were quantified using enzyme-linked immunosorbent assay (ELISA).
- Participants were stratified into four groups based on IL-10 concentrations.
- Metabolic risk factors included waist circumference, BMI, dyslipidemia, hypertension, and glucose intolerance.
Main Results:
- A significant inverse correlation was observed between plasma IL-10 levels and the mean number of metabolic risk factors.
- Reduced IL-10 levels were associated with an increased prevalence of obesity, dyslipidemia, high blood pressure, and glucose intolerance.
Conclusions:
- Circulating IL-10 levels demonstrate a negative correlation with the multiplicity of metabolic risk factors.
- IL-10 may function as a valuable biomarker for identifying children at risk of metabolic disorders.
Background:
Interleukin-10 (IL-10) is an adipocytokine that is abundantly expressed in visceral fat tissue. We investigated the association of interleukin-10 with the number of metabolic risk factors.
Finding:
The study population comprised 220 children who underwent annual health checkups. Plasma Interleukin-10 levels were determined by enzyme-linked immunosorbent assay. We divided the subjects into 4 groups according to Interleukin-10 levels. A reduction of plasma interleukin-10 levels significantly correlated with an increase in the mean number of metabolic risk factors such as increased waist circumference, BMI, dyslipidaemia, high blood pressure and glucose intolerance.
Conclusions:
Circulating Interleukin-10 levels negatively correlated with the multiplicity of metabolic risk factors, suggesting that IL-10 acts as a biomarker of metabolic disorders.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
What is Metabolism?
Relative Risk
Transcription Factors
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Factors Affecting Solubility

